methotrexate has been researched along with Cancer of the Urethra in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 6 (40.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abel, I; Clasen-Linde, E; Hansen, MF | 1 |
| Katz, EE; Krausz, T; Rapp, DE; Sokoloff, MH; Suzue, K; Wille, MA | 1 |
| Angel, JR; deKernion, JB; Kraus, SD; McClung, T; Roth, J | 1 |
| Akaza, H; Koiso, K; Miyanaga, N; Ohtani, M; Shimazui, T | 1 |
| Babaian, RJ; Dinney, CP; Johnson, DE; Swanson, DA; von Eschenbach, AC | 1 |
| de Mulder, P; Oosterhof, GO; Witjes, JA; Wullink, M | 1 |
| Aravantinos, G; Christodoulou, C; Dimopoulos, K; Fountzilas, G; Giannakakis, T; Kastriotis, I; Kostakopoulos, CA; Linardou, E; Picramenos, D; Skarlos, DV | 1 |
| Dillman, RO; Sheehy, PF; VanderMolen, LA | 1 |
| Ansari, MS; Aron, M; Datta Gupta, S; Doddamani, D; Gupta, NP; Singh, I | 1 |
| Eisenberger, MA | 1 |
| Fosså, SD; Hosbach, G; Ous, S; Sager, EM; Waehre, H | 1 |
| Hirano, A; Nakano, M; Shinagawa, T; Takahashi, H; Tanaka, K | 1 |
| Bander, N; Geller, N; Herr, HW; Morse, MJ; Scher, HI; Sogani, PC; Sternberg, CN; Vaughan, ED; Watson, RC; Yagoda, A | 1 |
| Fair, WR; Herr, HW; Morse, MJ; Reuter, V; Scher, HI; Sogani, PC; Sternberg, CN; Watson, RC; Whitmore, WF; Yagoda, A | 1 |
| Ahmed, T; Geller, N; Herr, HW; Hollander, PS; Scher, HI; Sogani, PC; Sternberg, CN; Watson, RC; Weiselberg, LR; Yagoda, A | 1 |
1 review(s) available for methotrexate and Cancer of the Urethra
| Article | Year |
|---|---|
Chemotherapy for carcinomas of the penis and urethra.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Humans; Male; Methotrexate; Penile Neoplasms; Urethral Neoplasms | 1992 |
3 trial(s) available for methotrexate and Cancer of the Urethra
| Article | Year |
|---|---|
The effect of dose intensity on M-VAC therapy for advanced urothelial cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Kidney Neoplasms; Kidney Pelvis; Longitudinal Studies; Male; Methotrexate; Middle Aged; Survival Rate; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1994 |
Toxicity and results of MVAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy in advanced urothelial carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Follow-Up Studies; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Nausea; Urethral Neoplasms; Urinary Bladder Neoplasms; Vinblastine; Vomiting | 1997 |
Chemotherapy with methotrexate, vinblastine, epirubicin and carboplatin (Carbo-MVE) in transitional cell urothelial cancer. A Hellenic Co-Operative Oncology Group study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystectomy; Disease Progression; Epirubicin; Female; Humans; Male; Methotrexate; Middle Aged; Treatment Outcome; Urethral Neoplasms; Urinary Bladder Neoplasms; Vinblastine; World Health Organization | 1997 |
11 other study(ies) available for methotrexate and Cancer of the Urethra
| Article | Year |
|---|---|
Primary malignant melanoma of the urethra in a patient with rheumatoid arthritis treated with methotrexate.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Melanoma; Methotrexate; Urethra; Urethral Neoplasms | 2019 |
Primary malignant melanoma of the urethra.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Diagnostic Errors; Doxorubicin; Humans; Lymph Node Excision; Male; Melanoma; Methotrexate; Neoplasm Invasiveness; Neoplasm Seeding; Penis; Prostatectomy; Urethral Neoplasms; Urinary Bladder Neoplasms; Urinary Diversion; Vinblastine | 2005 |
Unusual case of urethral carcinoma.
Topics: Carcinoma, Squamous Cell; Humans; Male; Methotrexate; Middle Aged; Postoperative Complications; Urethra; Urethral Neoplasms | 1981 |
Therapy and prognosis for male anterior urethral carcinoma: an update.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Follow-Up Studies; Humans; Lymph Node Excision; Male; Methotrexate; Middle Aged; Prognosis; Retrospective Studies; Survival Rate; Urethral Neoplasms; Vinblastine | 1994 |
Successful treatment of transitional cell carcinoma of the urethra with chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Black People; California; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoplasm Staging; Paclitaxel; Urethral Neoplasms; Vinblastine; White People | 2002 |
Mesonephroid adenocarcinoma of the bladder and urethra: a case report.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Female; Humans; Mesoderm; Methotrexate; Nephrons; Urethral Neoplasms; Urinary Bladder Neoplasms | 2002 |
Cisplatin and medium dose methotrexate in advanced transitional cell carcinoma of the urinary tract.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Humans; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Staging; Urethral Neoplasms; Urinary Bladder Neoplasms | 1990 |
[Primary carcinoma of the female urethra].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Humans; Methotrexate; Urethral Neoplasms; Vinblastine | 1989 |
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Female; Humans; Kidney Neoplasms; Liver Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1989 |
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Ureteral Neoplasms; Urethral Neoplasms; Urologic Neoplasms; Vinblastine | 1988 |
Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Radiotherapy Dosage; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1985 |